Abstract: An image processing device including: a gain value manager for generating white gain values corresponding to a plurality of positions, based on a sensing result of a predetermined white image; a target pixel manager for detecting saturated pixels, based on pixel values received from an external device, and determining target pixels as saturated white pixels of which each have a pixel value that indicates that the saturated white pixel is saturated, based on peripheral pixels of the saturated white pixels among the detected saturated pixels; and a target pixel corrector for changing pixel values of the target pixels, based on the white gain values and pixel values of the peripheral pixels.

Abstract: There are provided a semiconductor device and a manufacturing method thereof. The semiconductor device includes: a stack structure including a plurality of interlayer insulating layers and a plurality of gate conductive layers, which are stacked in an alternating manner; at least one support structure penetrating the stack structure in a substantially vertical manner, the at least one support structure being formed in a contact region; and a contact plug penetrating the stack structure in a substantially vertical manner, the contact plug being formed in the contact region, the contact plug being connected to a contact pad that is disposed on the bottom of the stack structure. The at least one support structure is formed of an oxide layer.

Abstract: A plant cultivation system. The system utilizes a trolley conveyor for transport of plants in plant containers. The trolley conveyor uses straight runs of track connected by curved track portions. The straight runs of track of the trolley conveyor are spaced closely together. The trolley conveyor is used to move plant containers to a workshop for planting, fertilization, watering, cultivation, and harvesting of plants or portions thereof, and for packaging of plants or portions thereof for shipment.

Abstract: A plant cultivation system for a plant factory that cultivates plants. The plant factory has a building with roof and walls, which may be in the form of a greenhouse with a roof and windows that may be opened and closed. A plant factory using the plant cultivation system cultivates plants for harvest and/or sale. The plant factory plant utilizes a trolley conveyor for transport of plants in plant containers. The trolley conveyor uses straight runs of track connected by curved track portions. The straight runs of track of the trolley conveyor are spaced closely together with space only provided for passage of plant containers in a side by side fashion, as no room for workers is necessary. The plant containers take the plant containers to workers in a workshop for planting, cultivation, harvesting of plants or portions thereof, and packaging of plants or portions thereof for shipment. As a result, labor is minimized, and the productivity of the plant factory is increased.

Abstract: The present invention relates to a novel YlMPO1 gene which plays an important role in mannosylphosphorylation of an industrial yeast Yarrowia lipolytica, and to a method for preparing a host system capable of producing recombinant glycoproteins free of mannosylphosphate by disruption of the gene. The mannosylphosphorylation is suppressed by the disruption of YlMPO1 gene according to the present invention, thereby achieving humanization of glycosylation pathway of Yarrowia lipolytica.

Abstract: The present invention relates to a novel YlMPOl gene which plays an important role in mannosylphosphorylation of an industrial yeast Yarrowia lipolytica, and to a method for preparing a host system capable of producing recombinant glycoproteins free of mannosylphosphate by disruption of the gene. The mannosylphosphorylation is suppressed by the disruption of YlMPOl gene according to the present invention, thereby achieving humanization of glycosylation pathway of Yarrowia lipolytica.

Abstract: The present invention relates to a nucleic acid molecule comprising the HpYPS1 gene encoding H. polymorpha yapsin1, a polypeptide encoded by the nucleic acid molecule, a H. polymorpha mutant strain having reduced yapsin activity by mutation of the HpYPS gene encoding H. polymorpha yapsin1, a recombinant H. polymorpha strain expressing a foreign protein produced by introducing a gene encoding the foreign protein into the H. polymorpha mutant strain, and a process for preparing a foreign protein comprising culturing the recombinant H. polymorpha strain under conditions to express the foreign protein and isolating the foreign protein from the culture.

Abstract: The present invention provides a human serum albumin-TIMP2 fusion protein having the amino acid sequence set forth in SEQ ID NO. 10, a polynucleotide encoding the same and a vector comprising the polynucleotide, a host cell transformed with the vector, a method for producing the human serum albumin-TIMP2 fusion protein and a pharmaceutical composition comprising the human serum albumin-TIMP2 fusion protein. The human serum albumin-TIMP2 fusion protein is stable and retains the activity of TIMP2, thus it can be used as a pharmaceutical composition to treat diseases related to angiogenesis and/or metastasis of cancer cells.

Abstract: The present invention relates to a nucleic acid molecule comprising the HpYPS1 gene encoding H. polymorpha yapsin1, a polypeptide encoded by the nucleic acid molecule, a H. polymorpha mutant strain having reduced yapsin activity by mutation of the HpYPS gene encoding H. polymorpha yapsin1, a recombinant H. polymorpha strain expressing a foreign protein produced by introducing a gene encoding the foreign protein into the H. polymorpha mutant strain, and a process for preparing a foreign protein comprising culturing the recombinant H. polymorpha strain under conditions to express the foreign protein and isolating the foreign protein from the culture.

Abstract: The present invention provides a human serum albumin-TIMP2 fusion protein having the amino acid sequence set forth in SEQ ID NO. 10, a polynucleotide encoding the same and a vector comprising the polynucleotide, a host cell transformed with the vector, a method for producing the human serum albumin-TIMP2 fusion protein and a pharmaceutical composition comprising the human serum albumin-TIMP2 fusion protein. The human serum albumin-TIMP2 fusion protein is stable and retains the activity of TIMP2, thus it can be used as a pharmaceutical composition to treat diseases related to angiogenesis and/or metastasis of cancer cells.

Abstract: Disclosed is an infinitely variable speed transmission, including: a speed changing mechanism for primarily changing power from an engine into a necessary speed ratio, including: a sun gear disposed on an input shaft for transmitting power generated from the engine; a plurality of planet rollers which are disposed around the sun gear at a predetermined distance from each other, each planet roller having a truncated cone-shape and being revolvable around the sun gear and rotatable about its axis; a carrier for connecting the planet rollers with each other; a movable ring disposed to be circumscribed on outer tangential line of the planet rollers and movable by moving member along a longitudinal direction of the planet rollers to change a rotational speed of the planet rollers by varying an operating diameter so that an output speed outputted through the carriers connecting the planet roller with each other can be varied; and a second speed changing mechanism for changing the output speed from the speed changin